Complications of Intrastromal Bevacizumab Injection after Lamellar Keratoplasty | ASCRS
Menu
Home Clinical Education Cornea Complications of Intrastromal Bevacizumab Injection after Lamellar Keratoplasty
Video
Complications of Intrastromal Bevacizumab Injection after Lamellar Keratoplasty
May 2020
Meeting: 2020 Virtual Annual Meeting
Presenter: Mohammad Soleimani, MD
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

In this report we describe complications of intrastromal bevacizumab injection for corneal neovascularization (CNV) after lamellar keratoplasty (LK) in two patients. We concluded that subconjunctival injection of bevacizumab may be a safer method for managing CNV.
Filed Under
Cornea medication bevacizumab keratoplasty keratitis complications management 2020 film
View more Films

This film was submitted to the 38th Annual ASCRS Film Festival within the 2020 ASCRS Virtual Annual Meeting.. 

Browse All 2020 Films

Related Content

Presentation
Serum Tears Plus
Stephen G. Slade, MD, FACS 03:00 minutes
July 2021
Presentation
Office Management of Infectious Keratitis
Brandon D. Ayres, MD 09:54 minutes
July 2021
Presentation
Latest Evidences on Lid Margin Disease Management
Elizabeth Yeu, MD 09:38 minutes
April 2022
Session
SPS-305 Medications (Preoperative, Postoperative, Intraoperative)
Lola M Grillo, MD 05:29 minutes
July 2021
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2024 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.